Greenleaf Trust »

Mirati Therapeutics shares owned by Greenleaf Trust

Quarter-by-quarter ownership of Mirati Therapeutics shares owned by Greenleaf Trust from 13F filings

Historical chart of Greenleaf Trust investment in Mirati Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Mirati Therapeutics held by Greenleaf Trust consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Mirati Therapeutics by Greenleaf Trust

Quarter filed Position value Share count Share price at filing
2023-12-31 $212k 3.6k 58.75

More positions owned by Greenleaf Trust

Stryker Corporation (SYK)
iShares Core S&P 500 Index Core S&p500 Etf (IVV)
iShares Core MSCI EAFE ETF Core Msci Eafe (IEFA)
iShares Core S&P Midcap 400 Index Core S&p Mcp Etf (IJH)
Microsoft Corporation (MSFT)
Apple (AAPL)
iShares MSCI Emerging Index Fund MFC Msci Emg Mkt Etf (EEM)
iShares Core S&P Smallcap 600 Index Core S&p Scp Etf (IJR)
Amazon (AMZN)
NVIDIA Corporation (NVDA)
Alphabet Inc. Cl C CL C (GOOG)
Visa Inc - Class A Cl A (V)
Berkshire Hathaway Cl B Cl B New (BRK.B)
Meta Platforms Inc. Cl A Cl A (META)
S&P 500 Index ETF Tr Unit (SPY)

View all positions for Greenleaf Trust

Top funds holding Mirati Therapeutics

EcoR1 Capital
Vanguard Group
venBio Select Advisor
Baker Bros. Advisors
Boxer Capital
Sawtooth Asset Management
Braslyn
Alpine Associates Management
Tang Capital Management
Paradigm Biocapital Advisors
Pentwater Capital Management
CSS
Hsbc Holdings
Norges Bank Investment Management
Alliancebernstein

View all funds holding Mirati Therapeutics